EUVIMEDEUVIMED entdecken
Crossref

Biphenyl-Trimeric PSMA Theranostic Platform Enables PET Imaging and Optical Detection of Prostate Cancer

Yimin Chen iD, Haonan Yu, Wanjia Liu, Ming Wang, Xinlin Wang, Xiaojun Zhang, Jinming Zhang, Shaobo Yao iD, Mengchao Cui iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c01166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Yimin Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron-Emission Tomography, Glutamate Carboxypeptidase II, Theranostic Nanomedicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, National Natural Science Foundation of China, Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) diagnosis faces challenges with current imaging tracers in sensitivity and contrast. We developed a biphenyl-trimeric PSMA-targeted theranostic system to address these challenges. A suite of trimeric PSMA probes (PSMA-T0-T6) was synthesized using a biphenyl scaffold and variable linkers, showing exceptional PSMA affinity (Ki = 0.11-0.60 nM). Preclinical studies demonstrated that [68Ga]Ga-PSMA-T3 provided superior tumor uptake (SUVmax 1.16 vs 0.61) and tumor-to-background ratios (TBR 26.82 vs 19.89) over [68Ga]Ga-PSMA-11 in 22Rv1 tumor-bearing mice. The optical counterpart, ICG-conjugated PSMA-T6, prolonged tumor retention with high tumor-to-muscle ratio (T/M = 7.3 at 24 h) and remarkable ex vivo specificity (T/M = 41.9). In first-in-human PET studies, [68Ga]Ga-PSMA-T3 showed comparable and enhanced detection rates of primary and metastatic lesions, particularly in liver and bone metastases, with higher TBR values than [68Ga]Ga-PSMA-11. Our biphenyl-trimeric PSMA platform demonstrates translational potential for enhanced diagnostic sensitivity and intraoperative management of PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsPositron-Emission TomographyGlutamate Carboxypeptidase IITheranostic NanomedicineRadiopharmaceuticalsAntigens, SurfaceMaleAnimalsHumansMiceCell Line, TumorGallium RadioisotopesOptical Imaging

Substanzen

Gallium RadioisotopesGlutamate Carboxypeptidase IIFOLH1 protein, humanRadiopharmaceuticalsAntigens, Surface

Autor:innen und Institutionen

  • Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China.
  • Department of PET/CT Diagnostic, Tianjin Medical University General Hospital, Tianjin 300052, China.
  • Department of Nuclear Medicine, The First Medical Centre of Chinese PLA General Hospital, Beijing 100853, China.
  • Center for Advanced Materials Research, Beijing Normal University at Zhuhai, Zhuhai 519087, China.

ORCID-Profile: Yimin Chen, Shaobo Yao, Mengchao Cui

Förderung

  • Natural Science Foundation of Fujian Province
  • National Natural Science Foundation of China
  • Fujian Province

Zitieren

APA

Chen, Y., Yu, H., Liu, W., Wang, M., Wang, X., Zhang, X., Zhang, J., Yao, S., & Cui, M. (2025). Biphenyl-Trimeric PSMA Theranostic Platform Enables PET Imaging and Optical Detection of Prostate Cancer. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c01166

Vancouver

Chen Y, Yu H, Liu W, Wang M, Wang X, Zhang X, et al. Biphenyl-Trimeric PSMA Theranostic Platform Enables PET Imaging and Optical Detection of Prostate Cancer. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c01166

BibTeX
@article{Chen2025,
  author = {Chen, Yimin and Yu, Haonan and Liu, Wanjia and Wang, Ming and Wang, Xinlin and Zhang, Xiaojun and Zhang, Jinming and Yao, Shaobo and Cui, Mengchao},
  title = {Biphenyl-Trimeric PSMA Theranostic Platform Enables PET Imaging and Optical Detection of Prostate Cancer},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c01166}
}
Kostenlos starten →